Creative Biolabs stands out in the race as brain diseases fuel a surge in demand for NHP biospecimens—cerebrospinal fluid (CSF)—functioning as the gold standard for validating next-gen brain therapies.

A landmark study about gene therapy recently reported in Nature Biotechnology indicating 27% cognitive improvement in Alzheimer's mice using circular RNA has set labs scrambling for high-quality NHP samples that are firmly determined as the gold standard for bridging preclinical breakthroughs to human trials.

"Monkey CSF is more than just liquid, but a roadmap to the brain," says a neurology scientist at Creative Biolabs, sharing views about recent AD biomarker studies. With millions of CNS tumor cases annually and Alzheimer's deaths projected to triple in coming years, researchers are betting big on NHPs to crack the blood-brain barrier puzzle.

The Heavy Hitter in NHP CSF Supply

Creative Biolabs strives to establish itself as the real deal in high-specific NHP biospecimens. With a product catalog reading like a neuro lab's dream sheet, the company now holds the unique title of the world's dedicated commercial supplier of CSF from rhesus, cynomolgus, and African green monkeys. What really sets them apart is a proprietary collection technique that minimizes protein degradation and preserves the molecular integrity of the sample at each batch. "It isn't just about volume—it's about fidelity," said the scientist. "We deliver validated samples with shipping turnaround under 72 hours. For high-stakes research, that's a game-changer."

The Top Picks

* Rhesus Monkey CSF: Tailor-made for tau protein studies in Alzheimer's R&D and related tauopathies. Comes with custom assay solutions and batch-specific QC.
* Cynomolgus Monkey CSF: Offered in a cryopreserved or fresh state and can play an important role in lots of tests and assays, including PCR, WB, immunoprecipitation, and immunofluorescent flow cytometry, which is the go-to for Parkinson's and depression models.
* African Green Monkey CSF: The only CSF on the market verified for blood-brain barrier (BBB) integrity. Perfect for drug delivery and exosome research.

For running ELISAs, LC-MS, or any emerging exosome isolation operations, those CSF biologicals can be a really handy toolkit of neuroscience discoveries.

2025's Can't-Miss Biotech Showdowns for Creative Biolabs

April 24, 2025 | NIH Spring Research Vendor Fair
May 7, 2025 | 23rd BioPharma Drug Discovery Nexus Conference
September 2025 | World Bispecific Summit
October 2025 | Exosome-Based Therapeutic Development Summit
November 2025 | World ADC San Diego
December 2025 | Antibody Engineering & Therapeutics (US) 2025

"Bring your toughest research questions," challenges the scientist. "We've got your projects covered."